Skip to main content
H.R. 4993 119th Congress House

Joe Fiandra Access to Home Infusion Act of 2025

Official title: To amend title XVIII of the Social Security Act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the Medicare program.

Introduced: August 19, 2025 Introduced by: Brian K. Fitzpatrick Republican · Pennsylvania See on congress.gov
Health Health care coverage and accessHealth technology, devices, suppliesHome and outpatient careMedicarePrescription drugs
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 10, 2025
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
Dec 10, 2025
Committee Consideration and Mark-up Session Held
Aug 19, 2025
Introduced in House
Aug 19, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now December 10, 2025

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.

 Plain-English summary Congressional Research Service

Joe Fiandra Access to Home Infusion Act of 2025

This bill provides for Medicare coverage of certain home infusion drugs that are administered by health care professionals at a beneficiary’s home.

Specifically, the bill provides for coverage of external infusion pumps and associated home infusion drugs for which (1) the prescription requires that the drug be administered by or under the supervision of a health care professional, (2) a qualified home infusion therapy supplier administers or supervises the administration of the drug at the beneficiary's home, and (3) the prescription requires that the drug be infused at least 12 times per year in a manner that requires the use of an external infusion pump. 

 Hearings & markups 1
 Related & companion bills 3
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 14

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 14 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4993: Joe Fiandra Access to Home Infusion Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-4993/
MLA
"H.R. 4993: Joe Fiandra Access to Home Infusion Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-4993/.
Bluebook (legal)
H.R. 4993, 119th Cong. (2026), https://openamerica.io/bill/119-HR-4993/.
Markdown link
[H.R. 4993: Joe Fiandra Access to Home Infusion Act of 2025](https://openamerica.io/bill/119-HR-4993/)
Report a problem